Delivery Order SPE2DB24D8002-SPE2DB24FJMSL

Award Date 8/6/24
Potential Completion Date 8/7/24
Potential Value $6.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DX15D8002|SPE2DX24F2WP4, was granted to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is a delivery order valued at $2,054.23 for the supply of 4564804060 ! YUVAFEM 10 MCG VAGINAL INSERT 18S, a pharmaceutical product. The contract is not set aside and is a firm fixed price arrangement. Dakota Drug, Inc. has been awarded an Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, identified as SPE2DB24D8001, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a firm fixed price of $1,928.41 and a completion date of June 25, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA...
This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKYZV, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc. The contract has a ceiling value of $11,519.50 and is structured as a firm fixed-price delivery order. It is not designated as a set-aside contract. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The company specializes in providing...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKYWG, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, which is a Delivery Order under the DLA Troop Support Medical's ECAT Generation V Program, is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, including prescription medications, medical devices, vaccines, and other healthcare-related items. The contract...
This federal contract award, identified as SPE2DX15D8003|SPE2DX24F7C5F, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,837.38 and a period of performance through January 26, 2024. The contract does not have a set-aside designation, indicating that it was competed...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,539.65, is a firm fixed-price delivery order with no set-aside designation. The contract provides for the delivery of pharmaceutical products, including treatments for conditions such as diabetes, asthma, COPD, hypertension, and autoimmune disorders. Specific...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract worth $8,454.30 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a performance period through December 6, 2023. This delivery order is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical's ECAT...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical. The contract falls under the DLA's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment. Through this single-award IDC, Dakota Drug, Inc. will provide a comprehensive range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide a variety of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract, identified as SPE2DX15D8002|SPE2DX24F2UW2, has a ceiling value of $4,825.71 and is a Firm Fixed Price Delivery Order with a completion date of February 9, 2024. Dakota Drug, Inc. is a key supplier...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB24FJMSL
    Delivery Order

This federal contract award, valued at $6,467.31, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a firm fixed-price delivery order for the provision of 4565365894 ! YUVAFEM 10 MCG VAGINAL INSERT 18S.

Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which enables the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This latest award further demonstrates Dakota Drug, Inc.'s position as a key supplier for the DLA's military medical supply chain, delivering critical medications and supplies to various defense healthcare facilities.

Generated 11/5/24, 9:22 AM